Currently out of the existing stock ratings of Bradley Canino, 70 are a BUY (77.78%), 20 are a HOLD (22.22%).

Bradley Canino

Work Performance Price Targets & Ratings Chart

Analyst Bradley Canino works at STIFEL with a stock forecast success ratio of 43.11% fulfilled within 112.25 days on average.

Bradley Canino’s has documented 177 price targets and ratings displayed on 16 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on CCCC, C4 Therapeutics  at 09-May-2024.

Wall Street Analyst Bradley Canino

Analyst best performing recommendations are on AFMD (AFFIMED NV).
The best stock recommendation documented was for ARVN (ARVINAS) at 11/8/2023. The price target of $42 was fulfilled within 49 days with a profit of $25.49 (154.39%) receiving and performance score of 31.51.

Average potential price target upside

ALXO Alx Oncology Holdings  ARVN Arvinas BPMC Blueprint Medicines Corp CCCC C4 Therapeutics  DCPH Deciphera Pharmaceuticals LLC TPTX Turning Point Therapeutics ZNTL Zentalis Pharmaceuticals Llc BDTX Black Diamond Therapeutics KYMR Kymera Therapeutics AFMD Affimed NV MRUS Merus BV RLAY Relay Therapeutics  KURA Kura Oncology SNDX Syndax Pharmaceuticals THRX Theseus Pharmaceuticals NUVL Nuvalent

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

23

1 months 10 days ago

0/2 (0%)

$16.62 (260.50%)

Buy

20

$6.38 (46.84%)

17.5

2 months 11 days ago

2/5 (40%)

$6.54 (48.59%)

202

Buy

18

$4.38 (32.16%)

5 months 14 days ago

1/5 (20%)

$5.74 (46.82%)

93

Buy

10

$-3.62 (-26.58%)

15

6 months 8 days ago

3/6 (50%)

$1.17 (13.25%)

265

Buy

11

$-2.62 (-19.24%)

8

7 months 11 days ago

4/4 (100%)

$1.91 (21.01%)

54

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Bradley Canino is most bullish on?

Potential upside of $33.35 has been obtained for ARVN (ARVINAS)

Which stock is Bradley Canino is most reserved on?

Potential downside of -$0.15 has been obtained for AFMD (AFFIMED NV)

What Year was the first public recommendation made by Bradley Canino?

On 2021

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?